Leap Therapeutics LPTX
55.24
0.81
1.49
%
已收盤：05/15 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 2.88 | 103.67 | -0.37 | -16,125 | -15 | |
| 2024Q3 | 2.57 | 102.22 | -0.43 | -17,855 | -18 | |
| 2024Q2 | 1.96 | 105.58 | -0.50 | -21,252 | -20 | |
| 2024Q1 | 2.66 | 107.27 | -0.51 | -14,825 | -14 | |
| 2023Q4 | 4.15 | 118.89 | -0.20 | -14,820 | -12 | |
| 2023Q3 | 1.38 | 108.30 | 0.23 | -14,833 | -14 | |
| 2023Q2 | 3.13 | 109.50 | -0.77 | -14,662 | -13 | |
| 2023Q1 | 3.40 | 102.06 | -3.24 | -42,726 | -42 | |
| 2022Q4 | 4.50 | 116.68 | -1.07 | -13,943 | -12 | |
| 2022Q3 | 8.80 | 101.36 | -1.33 | -15,288 | -15 | |
| 2022Q2 | 11.50 | 99.37 | -1.52 | -16,900 | -17 | |
| 2022Q1 | 17.50 | 102.68 | -0.90 | -10,632 | -10 | |
| 2021Q4 | 32.40 | 97.02 | -0.80 | -10,488 | -11 | |
| 2021Q3 | 40.10 | 109.07 | -1.50 | -12,140 | -11 | |
| 2021Q2 | 16.40 | 101.22 | -1.20 | -9,626 | -10 | |
| 2021Q1 | 19.00 | 100.57 | -1.20 | -9,172 | -9 | |
| 2020Q4 | 22.50 | 106.54 | -0.50 | -7,154 | -7 | |
| 2020Q3 | 19.80 | 106.65 | -0.10 | -7,508 | -7 | |
| 2020Q2 | 20.90 | 115.27 | -0.20 | -7,496 | -7 | |
| 2020Q1 | 15.80 | 88.39 | -5.50 | -6,381 | -7 |
